Rats were gonadectomized from birth to either 40 days (females) or 55 days (males) at 5-day intervals and treated for 4 days before sacrifice. Females were treated with estradiol benzoate (Eb) 0.05 µ g/100 g b.w.), males with testosterone propionate (Tp) (40 µ g/ 100 g b.w.), and controls with oil. At sacrifice RIA determinations were made of LH and FSH and the weights of uterus, ventral prostate and seminal vesicles recorded. In treated females plasma FSH and LH levels were lowered by treatment mainly from 20 to 35 days, ineffective at 40 days, and by 45 days had partially recovered effectiveness. In treated males at any age plasma FSH was lowered; LH was lowered only at certain ages. Uterine, seminal vesicle and prostate weight increased significantly when animals reached puberty. The female immature gonadotropin system seems to come under gonadal control later than the male’s and its sensitivity changes with maturation.

Keywords:
Puberty, Sex differences, Testosterone, Estrogen, Gonadotropins, Rats
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1973
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.